| GenSight Biologics SA operates as a biopharmaceutical company, which develops novel therapies for mitochondrial and neurodegenerative diseases for central nervous system based on its proprietary platform technologies that combine gene therapy on mitochondrial targeting and optogenetics. It also provides ophthalmology services, which develops products to restore eyesight to patients suffering from retinal diseases. The company was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Benn, Luk H. |
|
